Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $BLTE vs $MANE | Chartloom

Compare

$BLTE vs $MANE

Belite Bio Inc · Veradermics Inc

BLTE

Belite Bio Inc

MANE

Veradermics Inc

Compare $BLTE vs $MANE

Comparing Belite Bio Inc and Veradermics Inc

BLTEBelite Bio Inc

MANEVeradermics Inc

BLTEBelite Bio Inc

Market cap

$5.70B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

21.92x

Rev growth (TTM)

—

YTD performance

-4.6%

52W performance

91.6%

FCF yield

0.0%

MANEVeradermics Inc

Market cap

$4.86B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

208.0%

52W performance

208.0%

FCF yield

-2.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BLTE

MANE

Detailed metrics comparison

BLTE

Belite Bio Inc

MANE

Veradermics Inc

Market Cap

BLTE$5.70B

MANE$4.86B

Enterprise Value

BLTE$5.70B

MANE$4.54B

Price

BLTE$151.87

MANE$116.26

P/E Ratio

BLTEN/A

MANEN/A

P/S Ratio

BLTE0.00x

MANE0.00x

EV/Sales

BLTE0.00x

MANE0.00x

EV/EBITDA

BLTE0.00x

MANE0.00x

P/B Ratio

BLTE7.97x

MANE6.72x

P/FCF Ratio

BLTEN/A

MANEN/A

EV/FCF

BLTE0.00x

MANE-42.29x

PEG Ratio

BLTEN/A

MANEN/A

Forward P/E (NTM)

BLTEN/A

MANEN/A

Forward P/S (NTM)

BLTE21.92x

MANEN/A

Revenue (TTM)

BLTE$0

MANE$0

Revenue Growth (YoY)

BLTEN/A

MANEN/A

Forward Rev Growth

BLTE97.1%

MANE308.7%

Gross Margin (TTM)

BLTE0.0%

MANE0.0%

Operating Margin (TTM)

BLTE0.0%

MANE0.0%

EBITDA Margin (TTM)

BLTE0.0%

MANE0.0%

Net Margin (TTM)

BLTE0.0%

MANE0.0%

FCF Margin (TTM)

BLTEN/A

MANEN/A

Net Income (TTM)

BLTE$-116M

MANE$-137M

FCF (TTM)

BLTE$0

MANE$-107M

EPS (TTM)

BLTE-$3.07

MANE-$3.39

ROE (TTM)

BLTE-2687.0%

MANE-3549.0%

ROA (TTM)

BLTE-2626.0%

MANE-3463.0%

ROIC (TTM)

BLTE-2687.0%

MANE-3549.0%

Cash

BLTE$0

MANE$319M

Debt

BLTE$0

MANE$0

Net Cash/Debt

BLTE$0

MANE$319M

Current Ratio (TTM)

BLTE50.02x

MANE70.53x

Quick Ratio (TTM)

BLTE49.90x

MANE70.35x

Debt/Equity (TTM)

BLTE0.00x

MANE0.00x

Debt/Assets (TTM)

BLTE0.0%

MANE0.0%

Interest Coverage (TTM)

BLTEN/A

MANEN/A

Net Debt/EBITDA (TTM)

BLTE0.00x

MANE0.00x

Beta

BLTE-1.22

MANE-0.05

52W Performance

BLTE91.6%

MANE208.0%

YTD Performance

BLTE-4.6%

MANE208.0%

% from 52W High

BLTE-24.1%

MANE-15.0%

% from 52W Low

BLTE92.9%

MANE263.3%

Asset Turnover (TTM)

BLTE0.00x

MANE0.00x

FCF Yield (TTM)

BLTE0.0%

MANE-2.2%

Earnings Yield (TTM)

BLTE-2.0%

MANE-2.8%

Dividend Yield (TTM)

BLTEN/A

MANEN/A

Rule of 40

BLTE0.0

MANE0.0

EV/GP/RG

BLTEN/A

MANEN/A

Ticker research

View BLTE research View MANE research

Metric	BLTE Belite Bio Inc	MANE Veradermics Inc
Market & Valuation
Market Cap	$5.70B	$4.86B
Enterprise Value	$5.70B	$4.54B
Price	$151.87	$116.26
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.97x	6.72x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-42.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.92x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	97.1%	308.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-116M	$-137M
FCF (TTM)	$0	$-107M
EPS (TTM)	-$3.07	-$3.39
ROE (TTM)	-2687.0%	-3549.0%
ROA (TTM)	-2626.0%	-3463.0%
ROIC (TTM)	-2687.0%	-3549.0%
Financial Health
Cash	$0	$319M
Debt	$0	$0
Net Cash/Debt	$0	$319M
Current Ratio (TTM)	50.02x	70.53x
Quick Ratio (TTM)	49.90x	70.35x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.22	-0.05
52W Performance	91.6%	208.0%
YTD Performance	-4.6%	208.0%
% from 52W High	-24.1%	-15.0%
% from 52W Low	92.9%	263.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	0.0%	-2.2%
Earnings Yield (TTM)	-2.0%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BLTE research	View MANE research

Valuation

P/S Ratio

BLTE

0.00x

MANE

0.00x

EV/FCF

MANE

-42.29x

BLTE

0.00x

Growth & revenue

Forward Revenue Growth

MANE

308.7%

BLTE

97.1%

Profitability & performance

Gross Margin

BLTE

0.0%

MANE

0.0%

ROE

BLTE

-2687.0%

MANE

-3549.0%

FCF Yield %

BLTE

0.0%

MANE

-2.2%

52-Week Performance

MANE

208.0%

BLTE

91.6%

Detailed metrics comparison

BLTE

Belite Bio Inc

MANE

Veradermics Inc

Market Cap

BLTE$5.70B

MANE$4.86B

Enterprise Value

BLTE$5.70B

MANE$4.54B

Price

BLTE$151.87

MANE$116.26

P/E Ratio

BLTEN/A

MANEN/A

P/S Ratio

BLTE0.00x

MANE0.00x

EV/Sales

BLTE0.00x

MANE0.00x

EV/EBITDA

BLTE0.00x

MANE0.00x

P/B Ratio

BLTE7.97x

MANE6.72x

P/FCF Ratio

BLTEN/A

MANEN/A

EV/FCF

BLTE0.00x

MANE-42.29x

PEG Ratio

BLTEN/A

MANEN/A

Forward P/E (NTM)

BLTEN/A

MANEN/A

Forward P/S (NTM)

BLTE21.92x

MANEN/A

Revenue (TTM)

BLTE$0

MANE$0

Revenue Growth (YoY)

BLTEN/A

MANEN/A

Forward Rev Growth

BLTE97.1%

MANE308.7%

Gross Margin (TTM)

BLTE0.0%

MANE0.0%

Operating Margin (TTM)

BLTE0.0%

MANE0.0%

EBITDA Margin (TTM)

BLTE0.0%

MANE0.0%

Net Margin (TTM)

BLTE0.0%

MANE0.0%

FCF Margin (TTM)

BLTEN/A

MANEN/A

Net Income (TTM)

BLTE$-116M

MANE$-137M

FCF (TTM)

BLTE$0

MANE$-107M

EPS (TTM)

BLTE-$3.07

MANE-$3.39

ROE (TTM)

BLTE-2687.0%

MANE-3549.0%

ROA (TTM)

BLTE-2626.0%

MANE-3463.0%

ROIC (TTM)

BLTE-2687.0%

MANE-3549.0%

Cash

BLTE$0

MANE$319M

Debt

BLTE$0

MANE$0

Net Cash/Debt

BLTE$0

MANE$319M

Current Ratio (TTM)

BLTE50.02x

MANE70.53x

Quick Ratio (TTM)

BLTE49.90x

MANE70.35x

Debt/Equity (TTM)

BLTE0.00x

MANE0.00x

Debt/Assets (TTM)

BLTE0.0%

MANE0.0%

Interest Coverage (TTM)

BLTEN/A

MANEN/A

Net Debt/EBITDA (TTM)

BLTE0.00x

MANE0.00x

Beta

BLTE-1.22

MANE-0.05

52W Performance

BLTE91.6%

MANE208.0%

YTD Performance

BLTE-4.6%

MANE208.0%

% from 52W High

BLTE-24.1%

MANE-15.0%

% from 52W Low

BLTE92.9%

MANE263.3%

Asset Turnover (TTM)

BLTE0.00x

MANE0.00x

FCF Yield (TTM)

BLTE0.0%

MANE-2.2%

Earnings Yield (TTM)

BLTE-2.0%

MANE-2.8%

Dividend Yield (TTM)

BLTEN/A

MANEN/A

Rule of 40

BLTE0.0

MANE0.0

EV/GP/RG

BLTEN/A

MANEN/A

Ticker research

View BLTE research View MANE research

Metric	BLTE Belite Bio Inc	MANE Veradermics Inc
Market & Valuation
Market Cap	$5.70B	$4.86B
Enterprise Value	$5.70B	$4.54B
Price	$151.87	$116.26
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.97x	6.72x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-42.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.92x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	97.1%	308.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-116M	$-137M
FCF (TTM)	$0	$-107M
EPS (TTM)	-$3.07	-$3.39
ROE (TTM)	-2687.0%	-3549.0%
ROA (TTM)	-2626.0%	-3463.0%
ROIC (TTM)	-2687.0%	-3549.0%
Financial Health
Cash	$0	$319M
Debt	$0	$0
Net Cash/Debt	$0	$319M
Current Ratio (TTM)	50.02x	70.53x
Quick Ratio (TTM)	49.90x	70.35x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.22	-0.05
52W Performance	91.6%	208.0%
YTD Performance	-4.6%	208.0%
% from 52W High	-24.1%	-15.0%
% from 52W Low	92.9%	263.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	0.0%	-2.2%
Earnings Yield (TTM)	-2.0%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BLTE research	View MANE research